Literature DB >> 1911205

The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group.

M Keefe1, R M Mackie.   

Abstract

Previous reports have suggested that the relationship between survival and thickness of primary cutaneous malignant melanoma is not linear, but that there are natural breakpoints at which survival worsens in a step fashion. Nine hundred and ninety-seven cases of primary cutaneous malignant melanoma less than 9.75 mm thick, excised in Scotland between 1979 and 1983 inclusive, were examined to see if this could be confirmed. An adjusted Cox's regression analysis showed that age, sex, site and thickness were all significant predictors of survival. Thickness was grouped either empirically or by the breakpoints reported by other authors. It was then entered into a model either as a regressor or as a factored variable. The ranges 0-9.75 mm and 0-2 mm were studied separately. In the 0-9.75 mm range the factored variable was a statistically significant better fit than the regressor for each set of breakpoints, including an empirical analysis with eight groups. This suggests that there is no single best fit and that a step-effect is unlikely. Across the 0-2 mm range there was no significant improvement in the fit if thickness was entered as a factored variable, again indicating that a step effect is unlikely. We argue that there is no biological or statistical evidence to support the existence of natural breakpoints.

Entities:  

Mesh:

Year:  1991        PMID: 1911205      PMCID: PMC1977630          DOI: 10.1038/bjc.1991.357

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

2.  The natural break points for primary-tumor thickness in clinical Stage I melanoma.

Authors:  C L Day; R A Lew; M C Mihm; M N Harris; A W Kopf; A J Sober; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

3.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

4.  A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; N B Halpern; W A Maddox
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

5.  Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.

Authors:  K Søndergaard; G Schou
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease.

Authors:  F L Meyskens; D H Berdeaux; B Parks; T Tong; L Loescher; T E Moon
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

7.  A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease.

Authors:  C L Day; A J Sober; A W Kopf; R A Lew; M C Mihm; P Hennessey; F M Golomb; M N Harris; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; A Postel; W R Grier; M N Mintzis; T B Fitzpatrick
Journal:  Ann Surg       Date:  1981-04       Impact factor: 12.969

8.  Melanoma case survival rates in South Australia by histological type, thickness and level of tumour at diagnosis.

Authors:  A Bonett; D Roder; A Esterman
Journal:  Med J Aust       Date:  1986-06-23       Impact factor: 7.738

  8 in total
  3 in total

1.  [Histology of malignant tumors caused by UV light].

Authors:  M Megahed
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

2.  Professor Rona MacKie, Scottish dermatologist and melanoma authority.

Authors:  A Daunton; A R Shipman
Journal:  Int J Womens Dermatol       Date:  2015-10-01

3.  Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.

Authors:  H Thorpe; S R Brown; J R Sainsbury; T J Perren; V Hiley; M Dowsett; A Nejim; J M Brown
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.